312 related articles for article (PubMed ID: 26773344)
21. Sympathoinhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats.
Murzenok PP; Huang BS; Leenen FH
Hypertension; 2000 Feb; 35(2):631-6. PubMed ID: 10679509
[TBL] [Abstract][Full Text] [Related]
22. Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4'-hydroxypropranolol in dogs.
Muir WW; Sams RA; Schall SF
J Vet Pharmacol Ther; 1996 Aug; 19(4):259-67. PubMed ID: 8866453
[TBL] [Abstract][Full Text] [Related]
23. Benidipine hydrochloride--a new calcium-channel blocker of the dihydropyridine type. Pharmacokinetics, pharmacodynamics, tolerance and dose finding in mild to moderate hypertension.
Maier-Lenz H; Rode H; Lenau H; Thieme G; Wölke E; Kobayashi H; Kobayashi S; Oka T
Arzneimittelforschung; 1988 Nov; 38(11A):1757-63. PubMed ID: 3219156
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
Morita T; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
[TBL] [Abstract][Full Text] [Related]
25. Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats.
Brynne L; Paalzow LK; Karlsson MO
J Pharmacol Exp Ther; 1999 Aug; 290(2):664-71. PubMed ID: 10411576
[TBL] [Abstract][Full Text] [Related]
26. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol.
Vinceneux P; Canal M; Domart Y; Roux A; Cascio B; Orofiamma B; Larribaud J; Flouvat B; Carbon C
Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):153-8. PubMed ID: 2870990
[TBL] [Abstract][Full Text] [Related]
29. Hypotensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously and renal hypertensive rats.
Ishii R; Naruse T; Tagawa T; Ishida T; Namba K
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S374-6. PubMed ID: 9072434
[TBL] [Abstract][Full Text] [Related]
30. Nilvadipine: profile of a new calcium antagonist. An overview.
Rosenthal J
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.
Tea BS; Dam TV; Moreau P; Hamet P; deBlois D
Hypertension; 1999 Aug; 34(2):229-35. PubMed ID: 10454446
[TBL] [Abstract][Full Text] [Related]
32. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
[TBL] [Abstract][Full Text] [Related]
33. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
[TBL] [Abstract][Full Text] [Related]
34. Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers.
Weber C; Tam YK; Schmidtke-Schrezenmeier G; Jonkmann JH; van Brummelen P
Eur J Clin Pharmacol; 1996; 51(1):87-90. PubMed ID: 8880057
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic/pharmacodynamic modeling of the cardiovascular effects of beta blockers in humans.
Baek IH; Yun MH; Yun HY; Kwon KI
Arch Pharm Res; 2008 Jun; 31(6):814-21. PubMed ID: 18563366
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive activity of a new calcium channel blocker LF 2.0254, in spontaneously hypertensive rats: a comparison with nifedipine and nicardipine.
Pruneau D; Brown NL
Arch Int Pharmacodyn Ther; 1988; 295():109-24. PubMed ID: 2977540
[TBL] [Abstract][Full Text] [Related]
37. [The pharmacokinetic interaction of propranolol and nifedipine in patients with angina of effort].
Kukushkin SK; Rumiantsev DO; Belolipetskaia VG; Kokurina EV; Piotrovskiĭ VK; Metelitsa VI
Eksp Klin Farmakol; 1994; 57(1):32-5. PubMed ID: 8142860
[TBL] [Abstract][Full Text] [Related]
38. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
[TBL] [Abstract][Full Text] [Related]
39. Effect of policosanol on arterial blood pressure in rats. Study of the pharmacological interaction with nifedipine and propranolol.
Molina Cuevas V; Arruzazabala ML; Carbajal Quintana D; Más Ferreiro R; Valdés García S
Arch Med Res; 1998; 29(1):21-4. PubMed ID: 9556918
[TBL] [Abstract][Full Text] [Related]
40. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
